Alessandro Agosti
About Alessandro Agosti
Alessandro Agosti is an Associate Editor at ACS Chemical Health & Safety and has extensive experience in organic synthesis and process development. He holds a PhD from the University of Bern and has worked at prestigious institutions including MIT and Olon SpA.
Work at American Chemical Society
Alessandro Agosti serves as an Associate Editor for ACS Chemical Health & Safety at the American Chemical Society. He has held this position since 2020. In this role, he contributes to the editorial process, focusing on the publication of research that enhances safety in chemical practices. His expertise in chemical safety and risk assessment informs his editorial decisions, ensuring that the journal maintains high standards in disseminating relevant research.
Education and Expertise
Alessandro Agosti earned his Doctor of Philosophy (PhD) from the University of Bern, where he studied from 2004 to 2008. He also completed a postdoctoral fellowship at the Massachusetts Institute of Technology (MIT). His academic background is complemented by a Laurea in Industrial Chemistry from Università degli Studi di Milano, obtained from 1998 to 2004. Agosti specializes in organic synthesis of complex molecular architectures and synthetic planning for full-scale manufacturing, with a strong focus on process simulation tools such as Dynochem and CFD MixIt.
Professional Experience
Alessandro Agosti has extensive professional experience in the field of chemistry. He worked as a SNF Postdoctoral Fellow at MIT from 2009 to 2010. He then joined Olon SpA, where he served as Process Development Chemist and Head of Process Safety and Reaction Scale-up Laboratory from 2011 to 2022. Additionally, he was a researcher at Italcementi Group for a brief period in 2010. Currently, he is the Senior Director of Scientific Operations at Olon Ricerca Bioscience, a position he has held since 2022.
Research and Development Contributions
During his tenure at Olon SpA, Alessandro Agosti was involved in route scouting for new Active Pharmaceutical Ingredients (APIs) and impurities identification and synthesis. His work included conducting mixing studies and risk assessments, which are critical for ensuring safety in chemical processes. At MIT, he worked under Professor Tim Jamison, focusing on the development of methods for synthesizing marine natural products, contributing to advancements in organic synthesis methodologies.